RxDoctor Payments Data

Melinda Williams, NP

Nurse Practitioner · Fayetteville, TNNPI 1871548008

Payments from drug & device makers

$523in general payments, 2019–2025

Across 34 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$106
  • Novo Nordisk$76
  • Novartis$66
  • AbbVie$54
  • Amgen$48
  • Boehringer Ingelheim$39
  • plus $134 from 7 others

What the payments were for

  • Food & beverage$523100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$523 in reported general payments places this provider in the 65th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$25,974
Medicare patients
138
Services billed
520

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide90$94,498
JardianceEmpagliflozin23$23,647
LinzessLinaclotide23$22,619
FarxigaDapagliflozin Propanediol22$21,765
MounjaroTirzepatide15$15,007
EliquisApixaban16$14,673
Repatha SureclickEvolocumab20$12,700
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$11,992
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$11,897
Ezetimibe77$4,212
Dexlansoprazole DrDexlansoprazole12$3,291
Duloxetine Hcl70$2,876
Atorvastatin Calcium182$2,464
Rosuvastatin Calcium158$2,331
Esomeprazole Magnesium28$2,227

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$76$94,49890 claims
AstraZenecaFarxiga, Breztri Aerosphere$106$33,66242 claims
AbbVieLinzess, Synthroid$54$23,88936 claims
Boehringer IngelheimJardiance$39$23,64723 claims
Lilly USA, LLCMounjaro$17$15,00715 claims
PfizerEliquis$17$14,67316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Fayetteville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →